Published in Cell Cycle on August 15, 2006
Gadd45a is an RNA binding protein and is localized in nuclear speckles. PLoS One (2011) 0.93
Berberine inhibits proliferation and down-regulates epidermal growth factor receptor through activation of Cbl in colon tumor cells. PLoS One (2013) 0.93
The nucleolar detention pathway: A cellular strategy for regulating molecular networks. Cell Cycle (2012) 0.82
Effects of low doses of ionizing radiation exposures on stress-responsive gene expression in human embryonic stem cells. Int J Mol Sci (2014) 0.82
GADD45a physically and functionally interacts with TET1. Differentiation (2015) 0.76
Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One (2008) 8.97
Metastasis: a question of life or death. Nat Rev Cancer (2006) 6.26
Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell (2008) 5.88
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature (2008) 5.32
Retracted Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol (2009) 3.84
Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res (2009) 3.31
A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell (2013) 2.46
TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer. IARC Sci Publ (2004) 2.23
Interference with netrin-1 and tumor cell death in non-small cell lung cancer. J Natl Cancer Inst (2009) 2.16
ING2 controls the G1 to S-phase transition by regulating p21 expression. Cell Cycle (2010) 2.06
Real-time PCR based on SYBR-Green I fluorescence: an alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions. BMC Biotechnol (2003) 2.05
Human telomeric position effect is determined by chromosomal context and telomeric chromatin integrity. EMBO Rep (2002) 1.79
Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. Cancer Cell (2004) 1.71
Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas. PLoS Genet (2009) 1.55
Influence of neuroblastoma stage on serum-based detection of MYCN amplification. Pediatr Blood Cancer (2009) 1.49
EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice. PLoS Genet (2012) 1.47
Gadd45a activation protects melanoma cells from ultraviolet B-induced apoptosis. J Invest Dermatol (2007) 1.47
A p21/WAF1 mutation favors the appearance of drug resistance to paclitaxel in human noncancerous epithelial mammary cells. Int J Cancer (2006) 1.44
MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer. Cancer Res (2002) 1.41
Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs. J Hepatol (2013) 1.40
WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway. Cancer Res (2009) 1.39
Netrin-1 acts as a survival factor for aggressive neuroblastoma. J Exp Med (2009) 1.36
p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer. Cancer Cell (2013) 1.35
The CD10 enzyme is a key player to identify and regulate human mammary stem cells. Stem Cells (2010) 1.34
The new tumor suppressor genes ING: genomic structure and status in cancer. Int J Cancer (2008) 1.30
Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression. Cancer Res (2012) 1.26
Alterations of anaphase-promoting complex genes in human colon cancer cells. Oncogene (2003) 1.25
Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing. Hum Mutat (2006) 1.25
Cancer stem cells: the emerging challenge of drug targeting. Curr Med Chem (2009) 1.17
p53 as a target for anti-cancer drug development. Crit Rev Oncol Hematol (2006) 1.14
BMP4 regulation of human megakaryocytic differentiation is involved in thrombopoietin signaling. Blood (2008) 1.10
ING1 and ING2: multifaceted tumor suppressor genes. Cell Mol Life Sci (2013) 1.06
Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes. Breast Cancer Res Treat (2011) 1.04
p53 protein variants: structural and functional similarities with p63 and p73 isoforms. Oncogene (2004) 1.04
Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type. Hum Genet (2002) 1.03
Circulating MYCN DNA as a tumor-specific marker in neuroblastoma patients. Cancer Res (2002) 1.02
PLA2R1 mediates tumor suppression by activating JAK2. Cancer Res (2013) 1.01
Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation. Hum Mutat (2007) 0.99
The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells. J Cell Sci (2005) 0.99
The expression of TA and DeltaNp63 are regulated by different mechanisms in liver cells. Oncogene (2005) 0.98
Methylome analysis reveals Jak-STAT pathway deregulation in putative breast cancer stem cells. Epigenetics (2011) 0.97
TWIST1 a new determinant of epithelial to mesenchymal transition in EGFR mutated lung adenocarcinoma. PLoS One (2012) 0.96
BTG2, its family and its tutor. Bull Cancer (2004) 0.94
The tumor suppressor gene TP53: implications for cancer management and therapy. Crit Rev Clin Lab Sci (2004) 0.94
Circulating MYCN DNA predicts MYCN-amplification in neuroblastoma. J Clin Oncol (2005) 0.93
The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene. Gene (2002) 0.93
Genome-wide analysis of gene expression in neuroblastomas detected by mass screening. Cancer Lett (2004) 0.92
Mutational targets in colorectal cancer cells with microsatellite instability. Fam Cancer (2006) 0.91
BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells. Oncogene (2002) 0.91
Protein chip array profiling analysis of sera from neuroblastoma patients. Cancer Lett (2005) 0.90
Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein. Carcinogenesis (2010) 0.89
Chfr inactivation is not associated to chromosomal instability in colon cancers. Oncogene (2003) 0.89
Primitive CML cell expansion relies on abnormal levels of BMPs provided by the niche and on BMPRIb overexpression. Blood (2013) 0.89
Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result. Cancer Epidemiol Biomarkers Prev (2002) 0.88
Bromohydrin pyrophosphate-stimulated Vgamma9delta2 T cells expanded ex vivo from patients with poor-prognosis neuroblastoma lyse autologous primary tumor cells. J Immunother (2010) 0.88
TWIST1 expression in breast cancer cells facilitates bone metastasis formation. J Bone Miner Res (2014) 0.88
Effect of bortezomib on human neuroblastoma: analysis of molecular mechanisms involved in cytotoxicity. Mol Cancer (2008) 0.87
PLA2R1 kills cancer cells by inducing mitochondrial stress. Free Radic Biol Med (2013) 0.87
Deregulation of TWIST-1 in the CD34+ compartment represents a novel prognostic factor in chronic myeloid leukemia. Blood (2010) 0.87
Failsafe program escape and EMT: a deleterious partnership. Semin Cancer Biol (2011) 0.87
CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues. Blood (2011) 0.86
Variants in the netrin-1 receptor UNC5C prevent apoptosis and increase risk of familial colorectal cancer. Gastroenterology (2011) 0.86
Copper isotope effect in serum of cancer patients. A pilot study. Metallomics (2015) 0.84
Tif1γ is essential for the terminal differentiation of mammary alveolar epithelial cells and for lactation through SMAD4 inhibition. Development (2012) 0.84
Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine. Int J Cancer (2002) 0.84
Intensity-dependent constitutional MLH1 promoter methylation leads to early onset of colorectal cancer by affecting both alleles. Genes Chromosomes Cancer (2010) 0.84
Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer. BMC Cancer (2006) 0.84
The SNAIL family member SCRATCH1 is not expressed in human tumors. Oncol Rep (2010) 0.83
TP63 gene in stress response and carcinogenesis: a broader role than expected. Bull Cancer (2006) 0.83
In vitro and in vivo cytotoxic effects of PRIMA-1 on hepatocellular carcinoma cells expressing mutant p53ser249. Carcinogenesis (2007) 0.83
Caspase-dependent BRCA1 cleavage facilitates chemotherapy-induced apoptosis. Apoptosis (2008) 0.83
Influence of p53 and p21(WAF1) expression on sensitivity of cancer cells to cladribine. Biochem Pharmacol (2003) 0.82
Polymorphisms and HNPCC: PMS2-MLH1 protein interactions diminished by single nucleotide polymorphisms. Hum Mutat (2002) 0.82
Early origin of cancer metastases: dissemination and evolution of premalignant cells. Cell Cycle (2008) 0.82
ING2 controls the progression of DNA replication forks to maintain genome stability. EMBO Rep (2009) 0.80
ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells. Mol Cancer (2014) 0.80
Interhelical loops within the bHLH domain are determinant in maintaining TWIST1-DNA complexes. J Biomol Struct Dyn (2013) 0.80
Determination of 17q gain in patients with neuroblastoma by analysis of circulating DNA. Pediatr Blood Cancer (2011) 0.78
Weekly administration of paclitaxel induces long-term aneugenicity in nude mice. Cancer Biol Ther (2007) 0.78
βIII-Tubulin is required for interphase microtubule dynamics in untransformed human mammary epithelial cells. Eur J Cell Biol (2011) 0.78
Expression of candidate tumor suppressor gene ING2 is lost in non-small cell lung carcinoma. Lung Cancer (2009) 0.77
SharING out the roles in replicatING DNA. Cell Cycle (2009) 0.76
p21(Cip1) regulates cell-substrate adhesion and interphase microtubule dynamics in untransformed human mammary epithelial cells. Eur J Cell Biol (2011) 0.76
Modulation of oxidative stress by twist oncoproteins. PLoS One (2013) 0.76
Upstream ORF affects MYCN translation depending on exon 1b alternative splicing. BMC Cancer (2009) 0.75
Should we consider cancers as embryonic diseases or as consequences of stem-cell deregulation? Clin Med Oncol (2008) 0.75
[Tumour genomics: an unstable landscape]. Bull Cancer (2008) 0.75